- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01368484
Effect of Dietary DHA Supplementation on Sperm Quality
June 7, 2011 updated by: Instituto Valenciano de Infertilidad, IVI VALENCIA
Effect of Dietary DHA Supplementation on Sperm Quality.
The aim of this study is evaluated the effect of dietetic supplementation with DHA on human sperm quality, antioxidant capacity and sperm DNA damage.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Murcia, Spain, 30007
- Instituto Valenciano de Infertilidad
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Diagnosis of male factor.
Exclusion Criteria:
- Metabolic and genetic diseases.
- Oncological patients.
- Patients with anticoagulants treatment.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Sunflower oil
|
1500 mg sunflower/day for 10 weeks
|
Experimental: Docosahexanoic acid
|
1500mg/day for 10 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
sperm concentration
Time Frame: 5 weeks
|
million of spermatozoa per milimitre
|
5 weeks
|
Sperm motility
Time Frame: 5 weeks
|
Percentage of motile sperm.
|
5 weeks
|
Sperm morphology
Time Frame: 5 weeks
|
Percentage of sperm with normal morphology
|
5 weeks
|
Total capacity antioxidant
Time Frame: 5 weeks
|
Total antioxidant capacity (TAC)is a colorimetric assay that measure the combined antioxidant activities of all its non enzymatic constituents in seminal plasma.
|
5 weeks
|
Sperm DNA damage.
Time Frame: 5 weeks
|
DNA fragmentation analysis was evaluated by TUNEL test and measured by flow cytometry
|
5 weeks
|
Fatty acids measure.
Time Frame: 5 weeks
|
Fatty acid analysis in seminal plasma and spermatozoa were evaluated by gas chromatography.The percentage of each fatty acid class was expressed as percentage of total fatty acids.
|
5 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sperm in ejaculate
Time Frame: 5 weeks
|
Million of spermatozoa in eyaculate.
|
5 weeks
|
Volume of ejaculate.
Time Frame: 5 weeks
|
Eyaculated milliliters.
|
5 weeks
|
Sperm viability
Time Frame: 5 weeks
|
Porcentage of sperm whitout membrane damage
|
5 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Martinez Soto, Juan Carlos, IVI Murcia
- Study Director: Landeras Gutierrez, Jose, IVI Murcia
- Study Chair: Nicolas Arnau, Maria, IVI Murcia
- Study Chair: Fernandez Olmedilla, Laura, IVI Murcia
- Study Chair: Albero Pilar, IVI Murcia
- Study Chair: Domingo JC, University of Barcelona
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2009
Primary Completion (Actual)
December 1, 2010
Study Completion (Actual)
March 1, 2011
Study Registration Dates
First Submitted
June 7, 2011
First Submitted That Met QC Criteria
June 7, 2011
First Posted (Estimate)
June 8, 2011
Study Record Updates
Last Update Posted (Estimate)
June 8, 2011
Last Update Submitted That Met QC Criteria
June 7, 2011
Last Verified
June 1, 2011
More Information
Terms related to this study
Other Study ID Numbers
- IVI MUR 005-2009
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on SPERM
-
CREA Medicina de la Reproducción SLRecruitingIntracytoplasmic Sperm Injection | Sperm | MicrofluidicsSpain
-
IVI MadridRecruitingSperm | Sperm DNA Fragmentation | Male Fertility | TelomeresSpain
-
Rajavithi HospitalRecruitingAutologous Platelet-rich Plasma Supplement | Sperm Cryopreservation | Post-cryopreserved Sperm Quality | Semen AnalysisThailand
-
Assaf-Harofeh Medical CenterUnknownSperm CapacitationIsrael
-
The First Hospital of Jilin UniversityRecruiting
-
IVI SevillaRecruiting
-
University of TennesseeWithdrawn
-
Instituto Valenciano de Infertilidad, IVI VALENCIACompleted
Clinical Trials on Sunflower oil
-
Harvard School of Public Health (HSPH)CompletedCardiovascular Disease
-
Solae, LLCProvident Clinical ResearchCompletedCardiovascular Disease | Sudden Cardiac Death | Sudden Cardiac ArrestUnited States
-
Wageningen UniversityRadboud University Medical CenterCompletedMild Cognitive ImpairmentNetherlands
-
Medical University of ViennaUnknown
-
Instituto de Ciencia y Tecnología de Alimentos...Completed
-
Soroka University Medical CenterUnknown
-
Johns Hopkins Bloomberg School of Public HealthTribhuvan University, Nepal; Nepal Nutrition Intervention Project SarlahiCompletedNeonatal Sepsis | Neonatal MortalityNepal
-
University of CopenhagenAxellusCompletedObesity | Cardiovascular Disease | Metabolic Syndrome | GrowthDenmark
-
Ludwig-Maximilians - University of MunichEuropean UnionCompletedPhenylketonuriaGermany, Italy, Spain, United Kingdom
-
Bournemouth UniversityDorset HealthCare University NHS Foundation TrustCompletedMetabolic Ketosis | Cognitive Impairments, MildUnited Kingdom